Selected research
Industry Research
Hybrid Positron Emission Tomography (PET) Systems Industry Research Report 2026
Market perspective
The global Hybrid Positron Emission Tomography (PET) Systems market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Hybrid Positron Emission Tomography (PET) Systems is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Hybrid Positron Emission Tomography (PET) Systems is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Hybrid Positron Emission Tomography (PET) Systems is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Hybrid Positron Emission Tomography (PET) Systems include Agfa-Gevaert Group, Bruker, Canon Medical Systems Corporation, CMR Naviscan, Cubresa, FUJIFILM Holdings Corporation, General Electric, Hitachi and Koninklijke Philips, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Hybrid Positron Emission Tomography (PET) Systems market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Hybrid Positron Emission Tomography (PET) Systems Market by Company
Agfa-Gevaert Group
Bruker
Canon Medical Systems Corporation
CMR Naviscan
Cubresa
FUJIFILM Holdings Corporation
General Electric
Hitachi
Koninklijke Philips
Mediso
MinFound Medical Systems
Oncovision
Rigaku
Siemens Healthcare
Neusoft Corporation
Medtronic
Abbott
Hybrid Positron Emission Tomography (PET) Systems Segment by Type
Direct Imaging
Alternative Imaging
Indirect Imaging
Hybrid Positron Emission Tomography (PET) Systems Segment by Application
Hospitals
Diagnostic Imaging Centers
Others
Hybrid Positron Emission Tomography (PET) Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hybrid Positron Emission Tomography (PET) Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hybrid Positron Emission Tomography (PET) Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hybrid Positron Emission Tomography (PET) Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hybrid Positron Emission Tomography (PET) Systems manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hybrid Positron Emission Tomography (PET) Systems by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hybrid Positron Emission Tomography (PET) Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Direct Imaging
- Alternative Imaging
- Indirect Imaging
Applications
- Hospitals
- Diagnostic Imaging Centers
- Others
Companies covered
- Agfa-Gevaert Group
- Bruker
- Canon Medical Systems Corporation
- CMR Naviscan
- Cubresa
- FUJIFILM Holdings Corporation
- General Electric
- Hitachi
- Koninklijke Philips
- Mediso
- MinFound Medical Systems
- Oncovision
- Rigaku
- Siemens Healthcare
- Neusoft Corporation
- Medtronic
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Hybrid Positron Emission Tomography (PET) Systems Market Size (2021-2032)
- 2.2.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales (2021-2032)
- 2.2.3 Global Hybrid Positron Emission Tomography (PET) Systems Market Average Price (2021-2032)
- 2.3 Hybrid Positron Emission Tomography (PET) Systems by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Direct Imaging
- 2.3.3 Alternative Imaging
- 2.3.4 Indirect Imaging
- 2.4 Hybrid Positron Emission Tomography (PET) Systems by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Diagnostic Imaging Centers
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Hybrid Positron Emission Tomography (PET) Systems Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Hybrid Positron Emission Tomography (PET) Systems Revenue of Manufacturers (2021-2026)
- 3.4 Global Hybrid Positron Emission Tomography (PET) Systems Average Price by Manufacturers (2021-2026)
- 3.5 Global Hybrid Positron Emission Tomography (PET) Systems Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Hybrid Positron Emission Tomography (PET) Systems, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Hybrid Positron Emission Tomography (PET) Systems, Product Type & Application
- 3.8 Global Manufacturers of Hybrid Positron Emission Tomography (PET) Systems, Established Date
- 3.9 Global Hybrid Positron Emission Tomography (PET) Systems Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Agfa-Gevaert Group
- 4.1.1 Agfa-Gevaert Group Company Information
- 4.1.2 Agfa-Gevaert Group Business Overview
- 4.1.3 Agfa-Gevaert Group Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Agfa-Gevaert Group Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.1.5 Agfa-Gevaert Group Recent Developments
- 4.2 Bruker
- 4.2.1 Bruker Company Information
- 4.2.2 Bruker Business Overview
- 4.2.3 Bruker Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bruker Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.2.5 Bruker Recent Developments
- 4.3 Canon Medical Systems Corporation
- 4.3.1 Canon Medical Systems Corporation Company Information
- 4.3.2 Canon Medical Systems Corporation Business Overview
- 4.3.3 Canon Medical Systems Corporation Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Canon Medical Systems Corporation Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.3.5 Canon Medical Systems Corporation Recent Developments
- 4.4 CMR Naviscan
- 4.4.1 CMR Naviscan Company Information
- 4.4.2 CMR Naviscan Business Overview
- 4.4.3 CMR Naviscan Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 CMR Naviscan Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.4.5 CMR Naviscan Recent Developments
- 4.5 Cubresa
- 4.5.1 Cubresa Company Information
- 4.5.2 Cubresa Business Overview
- 4.5.3 Cubresa Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cubresa Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.5.5 Cubresa Recent Developments
- 4.6 FUJIFILM Holdings Corporation
- 4.6.1 FUJIFILM Holdings Corporation Company Information
- 4.6.2 FUJIFILM Holdings Corporation Business Overview
- 4.6.3 FUJIFILM Holdings Corporation Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 FUJIFILM Holdings Corporation Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.6.5 FUJIFILM Holdings Corporation Recent Developments
- 4.7 General Electric
- 4.7.1 General Electric Company Information
- 4.7.2 General Electric Business Overview
- 4.7.3 General Electric Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 General Electric Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.7.5 General Electric Recent Developments
- 4.8 Hitachi
- 4.8.1 Hitachi Company Information
- 4.8.2 Hitachi Business Overview
- 4.8.3 Hitachi Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hitachi Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.8.5 Hitachi Recent Developments
- 4.9 Koninklijke Philips
- 4.9.1 Koninklijke Philips Company Information
- 4.9.2 Koninklijke Philips Business Overview
- 4.9.3 Koninklijke Philips Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Koninklijke Philips Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.9.5 Koninklijke Philips Recent Developments
- 4.10 Mediso
- 4.10.1 Mediso Company Information
- 4.10.2 Mediso Business Overview
- 4.10.3 Mediso Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Mediso Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.10.5 Mediso Recent Developments
- 4.11 MinFound Medical Systems
- 4.11.1 MinFound Medical Systems Company Information
- 4.11.2 MinFound Medical Systems Business Overview
- 4.11.3 MinFound Medical Systems Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 MinFound Medical Systems Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.11.5 MinFound Medical Systems Recent Developments
- 4.12 Oncovision
- 4.12.1 Oncovision Company Information
- 4.12.2 Oncovision Business Overview
- 4.12.3 Oncovision Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Oncovision Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.12.5 Oncovision Recent Developments
- 4.13 Rigaku
- 4.13.1 Rigaku Company Information
- 4.13.2 Rigaku Business Overview
- 4.13.3 Rigaku Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Rigaku Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.13.5 Rigaku Recent Developments
- 4.14 Siemens Healthcare
- 4.14.1 Siemens Healthcare Company Information
- 4.14.2 Siemens Healthcare Business Overview
- 4.14.3 Siemens Healthcare Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Siemens Healthcare Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.14.5 Siemens Healthcare Recent Developments
- 4.15 Neusoft Corporation
- 4.15.1 Neusoft Corporation Company Information
- 4.15.2 Neusoft Corporation Business Overview
- 4.15.3 Neusoft Corporation Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Neusoft Corporation Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.15.5 Neusoft Corporation Recent Developments
- 4.16 Medtronic
- 4.16.1 Medtronic Company Information
- 4.16.2 Medtronic Business Overview
- 4.16.3 Medtronic Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Medtronic Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.16.5 Medtronic Recent Developments
- 4.17 Abbott
- 4.17.1 Abbott Company Information
- 4.17.2 Abbott Business Overview
- 4.17.3 Abbott Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Abbott Hybrid Positron Emission Tomography (PET) Systems Product Portfolio
- 4.17.5 Abbott Recent Developments
5 Global Hybrid Positron Emission Tomography (PET) Systems Market Scenario by Region
- 5.1 Global Hybrid Positron Emission Tomography (PET) Systems Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region: 2021-2032
- 5.2.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region: 2021-2026
- 5.2.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Region: 2027-2032
- 5.3 Global Hybrid Positron Emission Tomography (PET) Systems Revenue by Region: 2021-2032
- 5.3.1 Global Hybrid Positron Emission Tomography (PET) Systems Revenue by Region: 2021-2026
- 5.3.2 Global Hybrid Positron Emission Tomography (PET) Systems Revenue by Region: 2027-2032
- 5.4 North America Hybrid Positron Emission Tomography (PET) Systems Market Facts & Figures by Country
- 5.4.1 North America Hybrid Positron Emission Tomography (PET) Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2021-2032)
- 5.4.3 North America Hybrid Positron Emission Tomography (PET) Systems Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Hybrid Positron Emission Tomography (PET) Systems Market Facts & Figures by Country
- 5.5.1 Europe Hybrid Positron Emission Tomography (PET) Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2021-2032)
- 5.5.3 Europe Hybrid Positron Emission Tomography (PET) Systems Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Hybrid Positron Emission Tomography (PET) Systems Market Facts & Figures by Country
- 5.6.1 Asia Pacific Hybrid Positron Emission Tomography (PET) Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Hybrid Positron Emission Tomography (PET) Systems Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Hybrid Positron Emission Tomography (PET) Systems Market Facts & Figures by Country
- 5.7.1 South America Hybrid Positron Emission Tomography (PET) Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2021-2032)
- 5.7.3 South America Hybrid Positron Emission Tomography (PET) Systems Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Hybrid Positron Emission Tomography (PET) Systems Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Hybrid Positron Emission Tomography (PET) Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Hybrid Positron Emission Tomography (PET) Systems Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Type (2021-2032)
- 6.1.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Type (2021-2032) & (units)
- 6.1.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Market Share by Type (2021-2032)
- 6.2 Global Hybrid Positron Emission Tomography (PET) Systems Revenue by Type (2021-2032)
- 6.2.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Hybrid Positron Emission Tomography (PET) Systems Revenue Market Share by Type (2021-2032)
- 6.3 Global Hybrid Positron Emission Tomography (PET) Systems Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Application (2021-2032)
- 7.1.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Application (2021-2032) & (units)
- 7.1.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Market Share by Application (2021-2032)
- 7.2 Global Hybrid Positron Emission Tomography (PET) Systems Revenue by Application (2021-2032)
- 7.2.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Hybrid Positron Emission Tomography (PET) Systems Revenue Market Share by Application (2021-2032)
- 7.3 Global Hybrid Positron Emission Tomography (PET) Systems Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Hybrid Positron Emission Tomography (PET) Systems Value Chain Analysis
- 8.1.1 Hybrid Positron Emission Tomography (PET) Systems Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Hybrid Positron Emission Tomography (PET) Systems Production Mode & Process
- 8.2 Hybrid Positron Emission Tomography (PET) Systems Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Hybrid Positron Emission Tomography (PET) Systems Distributors
- 8.2.3 Hybrid Positron Emission Tomography (PET) Systems Customers
9 Global Hybrid Positron Emission Tomography (PET) Systems Analyzing Market Dynamics
- 9.1 Hybrid Positron Emission Tomography (PET) Systems Industry Trends
- 9.2 Hybrid Positron Emission Tomography (PET) Systems Industry Drivers
- 9.3 Hybrid Positron Emission Tomography (PET) Systems Industry Opportunities and Challenges
- 9.4 Hybrid Positron Emission Tomography (PET) Systems Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst